Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Lygodium japonicum spores can reduce inflammation by blocking certain cell signals.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

TLR3 activation helps improve skin and hair follicle healing in mice.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Upadacitinib effectively treats pyoderma gangrenosum.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

JAK inhibitors may reduce depression in people with alopecia areata.

The conclusion is that the IL-6/STAT3 activation affects p63 expression in healing wounds, which may help in hair follicle regeneration.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

More research is needed to understand and manage rheumatoid arthritis better.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Topical IKKα inhibitors may help prevent CCS tumours.

Activating TLR3 boosts autophagy gene expression in skin cells.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Certain immune cells, when activated by specific signals, can encourage hair growth.